Advertisement

Index by author

May 01, 1992; Volume 261,Issue 2

A

  1. Adler-Graschinsky, E

    1. Relaxant effects of beta-carbolines on rat aortic rings.
      B Elgoyhen, P S Lorenzo, M T Tellez-Iñón and E Adler-Graschinsky
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 534-539;

  2. Allan, A M

    1. Effects of lorazepam tolerance and withdrawal on GABAA receptor-operated chloride channels.
      A M Allan, L D Baier and X Zhang
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 395-402;

  3. Alm, P

    1. Functional effects, binding sites and immunolocalization of endothelin-1 in isolated penile tissues from man and rabbit.
      F Holmquist, H J Kirkeby, B Larsson, A Forman, P Alm and K E Andersson
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 795-802;

  4. Amenta, F

    1. Endothelial dopamine DA-1 receptor sites in the rabbit pulmonary artery: autoradiographic demonstration.
      A Ricci, W L Collier and F Amenta
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 830-834;

  5. Andersson, K E

    1. Functional effects, binding sites and immunolocalization of endothelin-1 in isolated penile tissues from man and rabbit.
      F Holmquist, H J Kirkeby, B Larsson, A Forman, P Alm and K E Andersson
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 795-802;

  6. Aoki, K

    1. Y-27152, a long-acting K+ channel opener with less tachycardia: antihypertensive effects in hypertensive rats and dogs in conscious state.
      T Nakajima, T Shinohara, O Yaoka, A Fukunari, K Shinagawa, K Aoki, A Katoh, T Yamanaka, M Setoguchi and T Tahara
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 730-736;

  7. Arch, J R

    1. The inhibitory effects of cromakalim and its active enantiomer BRL 38227 against various agonists in guinea pig and human airways: comparison with pinacidil and verapamil.
      S G Taylor, J R Arch, J Bond, D R Buckle, D J Shaw, J F Taylor and J S Ward
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 429-437;

  8. Arthus, M F

    1. Vasopressin antagonist inhibition of clotting factor release in the rhesus monkey (Macaca mulatta).
      L B Kinter, I McConnell, B T Goodwin, S Campbell, W F Huffman, M F Arthus, M Lonergan and D G Bichet
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 462-469;

  9. Arts, K S

    1. Involvement of dynorphin A and not substance P in the spinal antianalgesic action of capsaicin against morphine-induced antinociception in mice.
      K S Arts, J M Fujimoto and L F Tseng
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 643-651;

B

  1. Baier, L D

    1. Effects of lorazepam tolerance and withdrawal on GABAA receptor-operated chloride channels.
      A M Allan, L D Baier and X Zhang
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 395-402;

  2. Bailey, J

    1. AHR-9294: a novel inhibitor of H,K-ATPase antagonizes gastric HCl secretion in vivo.
      W W Reenstra, L M Pinkus, J Bailey, W L Smith, D Droppleman, L F Sancilio and J G Forte
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 737-745;

  3. Bélanger, P M

    1. Effect of inflammation on the rabbit hepatic cytochrome P-450 isoenzymes: alterations in the kinetics and dynamics of tolbutamide.
      C Parent, P M Bélanger, L Jutras and P du Souich
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 780-787;

  4. Ben-Harari, R R

    1. Phasic responses to carbachol in isolated guinea pig trachea are augmented by cooling and inhibited by nifedipine.
      T M Tagliente, B A Dalton and R R Ben-Harari
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 755-763;

  5. Bennett, B M

    1. Hepatic cytochrome P-450-mediated activation of rat aortic guanylyl cyclase by glyceryl trinitrate.
      B M Bennett, B J McDonald and M J St James
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 716-723;

  6. Bergman, J

    1. Modulation of the discriminative stimulus effects of cocaine by mu and kappa opioids.
      R D Spealman and J Bergman
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 607-615;

  7. Bettendorf, A F

    1. Evidence that carbamazepine and antiepilepsirine may produce a component of their anticonvulsant effects by activating serotonergic neurons in genetically epilepsy-prone rats.
      Q S Yan, P K Mishra, R L Burger, A F Bettendorf, P C Jobe and J W Dailey
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 652-659;

  8. Bichet, D G

    1. Vasopressin antagonist inhibition of clotting factor release in the rhesus monkey (Macaca mulatta).
      L B Kinter, I McConnell, B T Goodwin, S Campbell, W F Huffman, M F Arthus, M Lonergan and D G Bichet
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 462-469;

  9. Blanc, G

    1. Nicotine and morphine differentially activate brain dopamine in prefrontocortical and subcortical terminal fields: effects of acute and repeated injections.
      P Vezina, G Blanc, J Glowinski and J P Tassin
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 484-490;

  10. Bond, J

    1. The inhibitory effects of cromakalim and its active enantiomer BRL 38227 against various agonists in guinea pig and human airways: comparison with pinacidil and verapamil.
      S G Taylor, J R Arch, J Bond, D R Buckle, D J Shaw, J F Taylor and J S Ward
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 429-437;

  11. Borghgraef, P

    1. Liarozole, an inhibitor of retinoic acid metabolism, exerts retinoid-mimetic effects in vivo.
      J Van Wauwe, G Van Nyen, M C Coene, P Stoppie, W Cools, J Goossens, P Borghgraef and P A Janssen
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 773-779;

  12. Brat, D J

    1. Emulsifier for intravenous cyclosporin inhibits neurite outgrowth, causes deficits in rapid axonal transport and leads to structural abnormalities in differentiating N1E.115 neuroblastoma.
      D J Brat, A J Windebank and S Brimijoin
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 803-810;

  13. Brimijoin, S

    1. Emulsifier for intravenous cyclosporin inhibits neurite outgrowth, causes deficits in rapid axonal transport and leads to structural abnormalities in differentiating N1E.115 neuroblastoma.
      D J Brat, A J Windebank and S Brimijoin
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 803-810;

  14. Buckle, D R

    1. The inhibitory effects of cromakalim and its active enantiomer BRL 38227 against various agonists in guinea pig and human airways: comparison with pinacidil and verapamil.
      S G Taylor, J R Arch, J Bond, D R Buckle, D J Shaw, J F Taylor and J S Ward
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 429-437;

  15. Burger, R L

    1. Evidence that carbamazepine and antiepilepsirine may produce a component of their anticonvulsant effects by activating serotonergic neurons in genetically epilepsy-prone rats.
      Q S Yan, P K Mishra, R L Burger, A F Bettendorf, P C Jobe and J W Dailey
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 652-659;

  16. Burkhart-Kasch, S

    1. Acute sensitivity of FAST and SLOW mice to the effects of abused drugs on locomotor activity.
      T J Phillips, S Burkhart-Kasch, C C Gwiazdon and J C Crabbe
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 525-533;

C

  1. Campbell, S

    1. Vasopressin antagonist inhibition of clotting factor release in the rhesus monkey (Macaca mulatta).
      L B Kinter, I McConnell, B T Goodwin, S Campbell, W F Huffman, M F Arthus, M Lonergan and D G Bichet
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 462-469;

  2. Cano, C

    1. Adenosine receptor-mediated alterations in prostacyclin production and cardiac function in the isolated rabbit heart.
      C Cano and K U Malik
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 660-668;

  3. Chatton, J Y

    1. Transport of salicylic acid through monolayers of a kidney epithelial cell line (LLC-PK1).
      J Y Chatton and F Roch-Ramel
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 518-524;

  4. Chaudhry, A

    1. Perinatal changes in the coupling of beta 1- and beta 3 adrenergic receptors to brown fat adenylyl cyclase.
      A Chaudhry, K N Lahners and J G Granneman
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 633-637;

  5. Chung, I

    1. Dual action of 2,3-butanedione monoxime (BDM) on K+ current in human T lymphocytes.
      L C Schlichter, P A Pahapill and I Chung
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 438-446;

  6. Coccini, T

    1. Benzimidazolone derivatives: a new class of 5-hydroxytryptamine4 receptor agonists with prokinetic and acetylcholine releasing properties in the guinea pig ileum.
      C A Rizzi, T Coccini, L Onori, L Manzo and M Tonini
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 412-419;

  7. Coene, M C

    1. Liarozole, an inhibitor of retinoic acid metabolism, exerts retinoid-mimetic effects in vivo.
      J Van Wauwe, G Van Nyen, M C Coene, P Stoppie, W Cools, J Goossens, P Borghgraef and P A Janssen
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 773-779;

  8. Coffman, W J

    1. Pharmacological assessment of the antithrombotic activity of the peptide thrombin inhibitor, D-methyl-phenylalanyl-prolyl-arginal (GYKI-14766), in a canine model of coronary artery thrombosis.
      C V Jackson, V G Crowe, J D Frank, H C Wilson, W J Coffman, B G Utterback, J A Jakubowski and G F Smith
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 546-552;

  9. Collier, W L

    1. Endothelial dopamine DA-1 receptor sites in the rabbit pulmonary artery: autoradiographic demonstration.
      A Ricci, W L Collier and F Amenta
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 830-834;

  10. Cools, W

    1. Liarozole, an inhibitor of retinoic acid metabolism, exerts retinoid-mimetic effects in vivo.
      J Van Wauwe, G Van Nyen, M C Coene, P Stoppie, W Cools, J Goossens, P Borghgraef and P A Janssen
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 773-779;

  11. Crabbe, J C

    1. Acute sensitivity of FAST and SLOW mice to the effects of abused drugs on locomotor activity.
      T J Phillips, S Burkhart-Kasch, C C Gwiazdon and J C Crabbe
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 525-533;

  12. Crowe, V G

    1. Pharmacological assessment of the antithrombotic activity of the peptide thrombin inhibitor, D-methyl-phenylalanyl-prolyl-arginal (GYKI-14766), in a canine model of coronary artery thrombosis.
      C V Jackson, V G Crowe, J D Frank, H C Wilson, W J Coffman, B G Utterback, J A Jakubowski and G F Smith
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 546-552;

D

  1. Dafnis, E

    1. Effect of lithium and amiloride on collecting tubule transport enzymes.
      E Dafnis, N A Kurtzman and S Sabatini
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 701-706;

  2. Dailey, J W

    1. Evidence that carbamazepine and antiepilepsirine may produce a component of their anticonvulsant effects by activating serotonergic neurons in genetically epilepsy-prone rats.
      Q S Yan, P K Mishra, R L Burger, A F Bettendorf, P C Jobe and J W Dailey
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 652-659;

  3. Dalton, B A

    1. Phasic responses to carbachol in isolated guinea pig trachea are augmented by cooling and inhibited by nifedipine.
      T M Tagliente, B A Dalton and R R Ben-Harari
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 755-763;

  4. Dass, C

    1. Human cytochrome P450 metabolism of teniposide and etoposide.
      M V Relling, R Evans, C Dass, D M Desiderio and J Nemec
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 491-496;

  5. Desiderio, D M

    1. Human cytochrome P450 metabolism of teniposide and etoposide.
      M V Relling, R Evans, C Dass, D M Desiderio and J Nemec
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 491-496;

  6. De Waele, J P

    1. The alcohol-preferring C57BL/6 mice present an enhanced sensitivity of the hypothalamic beta-endorphin system to ethanol than the alcohol-avoiding DBA/2 mice.
      J P De Waele, D N Papachristou and C Gianoulakis
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 788-794;

  7. Droppleman, D

    1. AHR-9294: a novel inhibitor of H,K-ATPase antagonizes gastric HCl secretion in vivo.
      W W Reenstra, L M Pinkus, J Bailey, W L Smith, D Droppleman, L F Sancilio and J G Forte
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 737-745;

  8. Dunwiddie, T V

    1. Direct in vitro electrochemical measurement of dopamine overflow in intermediate pituitary: characterization and pharmacology.
      P J Williams, T V Dunwiddie and G A Gerhardt
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 403-411;

  9. du Souich, P

    1. Effect of inflammation on the rabbit hepatic cytochrome P-450 isoenzymes: alterations in the kinetics and dynamics of tolbutamide.
      C Parent, P M Bélanger, L Jutras and P du Souich
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 780-787;

E

  1. Elayan, I

    1. Effects of 3,4-dihydroxymethamphetamine and 2,4,5-trihydroxymethamphetamine, two metabolites of 3,4-methylenedioxymethamphetamine, on central serotonergic and dopaminergic systems.
      M Johnson, I Elayan, G R Hanson, R L Foltz, J W Gibb and H K Lim
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 447-453;

  2. Elgoyhen, B

    1. Relaxant effects of beta-carbolines on rat aortic rings.
      B Elgoyhen, P S Lorenzo, M T Tellez-Iñón and E Adler-Graschinsky
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 534-539;

  3. Evans, R

    1. Human cytochrome P450 metabolism of teniposide and etoposide.
      M V Relling, R Evans, C Dass, D M Desiderio and J Nemec
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 491-496;

F

  1. Farhat, M Y

    1. Estradiol potentiates the vasopressor response of the isolated perfused rat lung to the thromboxane mimic U-46619.
      M Y Farhat and P W Ramwell
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 686-691;

  2. Fenoy, F J

    1. Effect of clentiazem on arterial pressure and renal function in normotensive and hypertensive rats.
      F J Fenoy, I Milicic, M Mistry, T E Mecca and R J Roman
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 470-475;

  3. Findlay, I

    1. Inhibition of ATP-sensitive K+ channels in cardiac muscle by the sulphonylurea drug glibenclamide.
      I Findlay
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 540-545;

  4. Fischman, M W

    1. The cardiovascular and subjective effects of intravenous cocaine and morphine combinations in humans.
      R W Foltin and M W Fischman
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 623-632;

  5. Foltin, R W

    1. The cardiovascular and subjective effects of intravenous cocaine and morphine combinations in humans.
      R W Foltin and M W Fischman
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 623-632;

  6. Foltz, R L

    1. Effects of 3,4-dihydroxymethamphetamine and 2,4,5-trihydroxymethamphetamine, two metabolites of 3,4-methylenedioxymethamphetamine, on central serotonergic and dopaminergic systems.
      M Johnson, I Elayan, G R Hanson, R L Foltz, J W Gibb and H K Lim
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 447-453;

  7. Forman, A

    1. Functional effects, binding sites and immunolocalization of endothelin-1 in isolated penile tissues from man and rabbit.
      F Holmquist, H J Kirkeby, B Larsson, A Forman, P Alm and K E Andersson
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 795-802;

  8. Forte, J G

    1. AHR-9294: a novel inhibitor of H,K-ATPase antagonizes gastric HCl secretion in vivo.
      W W Reenstra, L M Pinkus, J Bailey, W L Smith, D Droppleman, L F Sancilio and J G Forte
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 737-745;

  9. Foy, R A

    1. Characterization of 5-hydroxytryptamine receptors in bovine coronary arteries.
      R A Foy, J L Myles and R D Wilkerson
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 601-606;

  10. Frank, J D

    1. Pharmacological assessment of the antithrombotic activity of the peptide thrombin inhibitor, D-methyl-phenylalanyl-prolyl-arginal (GYKI-14766), in a canine model of coronary artery thrombosis.
      C V Jackson, V G Crowe, J D Frank, H C Wilson, W J Coffman, B G Utterback, J A Jakubowski and G F Smith
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 546-552;

  11. Fujimoto, J M

    1. Involvement of dynorphin A and not substance P in the spinal antianalgesic action of capsaicin against morphine-induced antinociception in mice.
      K S Arts, J M Fujimoto and L F Tseng
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 643-651;

  12. Fukunari, A

    1. Y-27152, a long-acting K+ channel opener with less tachycardia: antihypertensive effects in hypertensive rats and dogs in conscious state.
      T Nakajima, T Shinohara, O Yaoka, A Fukunari, K Shinagawa, K Aoki, A Katoh, T Yamanaka, M Setoguchi and T Tahara
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 730-736;

  13. Fung, H L

    1. Pharmacokinetic/pharmacodynamic relationship of the duration of vasodilating action of organic mononitrates in rats.
      T B Tzeng and H L Fung
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 692-700;

G

  1. Galloway, M P

    1. Acute administration of amphetamine: differential regulation of dopamine synthesis in dopamine projection fields.
      C B Tyler and M P Galloway
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 567-573;

  2. Garris, P A

    1. Effect of chronic haloperidol treatment on stimulated synaptic overflow of dopamine in the rat striatum.
      D J Wiedemann, P A Garris, J A Near and R M Wightman
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 574-579;

  3. Gerhardt, G A

    1. Direct in vitro electrochemical measurement of dopamine overflow in intermediate pituitary: characterization and pharmacology.
      P J Williams, T V Dunwiddie and G A Gerhardt
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 403-411;

  4. Gianoulakis, C

    1. The alcohol-preferring C57BL/6 mice present an enhanced sensitivity of the hypothalamic beta-endorphin system to ethanol than the alcohol-avoiding DBA/2 mice.
      J P De Waele, D N Papachristou and C Gianoulakis
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 788-794;

  5. Gibb, J W

    1. Effects of 3,4-dihydroxymethamphetamine and 2,4,5-trihydroxymethamphetamine, two metabolites of 3,4-methylenedioxymethamphetamine, on central serotonergic and dopaminergic systems.
      M Johnson, I Elayan, G R Hanson, R L Foltz, J W Gibb and H K Lim
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 447-453;
    2. Effect of flunarizine and nimodipine on the decrease in tryptophan hydroxylase activity induced by methamphetamine and 3,4-methylenedioxymethamphetamine.
      M Johnson, K Mitros, D M Stone, R Zobrist, G R Hanson and J W Gibb
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 586-591;

  6. Glowinski, J

    1. Nicotine and morphine differentially activate brain dopamine in prefrontocortical and subcortical terminal fields: effects of acute and repeated injections.
      P Vezina, G Blanc, J Glowinski and J P Tassin
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 484-490;

  7. Gold, L H

    1. Role of different brain structures in the expression of the physical morphine withdrawal syndrome.
      R Maldonado, L Stinus, L H Gold and G F Koob
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 669-677;

  8. Goodwin, B T

    1. Vasopressin antagonist inhibition of clotting factor release in the rhesus monkey (Macaca mulatta).
      L B Kinter, I McConnell, B T Goodwin, S Campbell, W F Huffman, M F Arthus, M Lonergan and D G Bichet
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 462-469;

  9. Goossens, J

    1. Liarozole, an inhibitor of retinoic acid metabolism, exerts retinoid-mimetic effects in vivo.
      J Van Wauwe, G Van Nyen, M C Coene, P Stoppie, W Cools, J Goossens, P Borghgraef and P A Janssen
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 773-779;

  10. Granneman, J G

    1. Perinatal changes in the coupling of beta 1- and beta 3 adrenergic receptors to brown fat adenylyl cyclase.
      A Chaudhry, K N Lahners and J G Granneman
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 633-637;
    2. Effects of agonist exposure on the coupling of beta 1 and beta 3 adrenergic receptors to adenylyl cyclase in isolated adipocytes.
      J G Granneman
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 638-642;

  11. Gwiazdon, C C

    1. Acute sensitivity of FAST and SLOW mice to the effects of abused drugs on locomotor activity.
      T J Phillips, S Burkhart-Kasch, C C Gwiazdon and J C Crabbe
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 525-533;

H

  1. Hamann, S R

    1. Opioid and nicotinic analgesic and hyperalgesic loci in the rat brain stem.
      S R Hamann and W R Martin
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 707-715;

  2. Hanson, G R

    1. Effects of 3,4-dihydroxymethamphetamine and 2,4,5-trihydroxymethamphetamine, two metabolites of 3,4-methylenedioxymethamphetamine, on central serotonergic and dopaminergic systems.
      M Johnson, I Elayan, G R Hanson, R L Foltz, J W Gibb and H K Lim
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 447-453;
    2. Effect of flunarizine and nimodipine on the decrease in tryptophan hydroxylase activity induced by methamphetamine and 3,4-methylenedioxymethamphetamine.
      M Johnson, K Mitros, D M Stone, R Zobrist, G R Hanson and J W Gibb
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 586-591;

  3. Harris, G C

    1. Sensitization of locus ceruleus neurons during withdrawal from chronic stimulants and antidepressants.
      G C Harris and J T Williams
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 476-483;

  4. Hikasa, Y

    1. Alpha adrenoceptor subtypes involved in the emetic action in dogs.
      Y Hikasa, S Ogasawara and K Takase
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 746-754;

  5. Hill, H F

    1. Use of 2-hydroxypropyl-beta-cyclodextrin as an intrathecal drug vehicle with opioids.
      J Jang, T L Yaksh and H F Hill
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 592-600;

  6. Holmquist, F

    1. Functional effects, binding sites and immunolocalization of endothelin-1 in isolated penile tissues from man and rabbit.
      F Holmquist, H J Kirkeby, B Larsson, A Forman, P Alm and K E Andersson
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 795-802;

  7. Hori, M

    1. Myosin phosphorylation-independent contraction induced by phorbol ester in vascular smooth muscle.
      K Sato, M Hori, H Ozaki, H Takano-Ohmuro, T Tsuchiya, H Sugi and H Karaki
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 497-505;
    2. Receptor agonists induce myosin phosphorylation-dependent and phosphorylation-independent contractions in vascular smooth muscle.
      M Hori, K Sato, K Sakata, H Ozaki, H Takano-Ohmuro, T Tsuchiya, H Sugi, I Kato and H Karaki
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 506-512;

  8. Huffman, W F

    1. Vasopressin antagonist inhibition of clotting factor release in the rhesus monkey (Macaca mulatta).
      L B Kinter, I McConnell, B T Goodwin, S Campbell, W F Huffman, M F Arthus, M Lonergan and D G Bichet
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 462-469;

  9. Hyde, J F

    1. Prolactin regulates maternal bile secretory function post partum.
      Y Liu, J F Hyde and M Vore
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 560-566;

I

  1. Ingenito, A J

    1. Centrally mediated cardiovascular actions of dynorphin A(1-8) on rat hippocampal formation.
      J Q Wang and A J Ingenito
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 678-685;

J

  1. Jackson, C V

    1. Pharmacological assessment of the antithrombotic activity of the peptide thrombin inhibitor, D-methyl-phenylalanyl-prolyl-arginal (GYKI-14766), in a canine model of coronary artery thrombosis.
      C V Jackson, V G Crowe, J D Frank, H C Wilson, W J Coffman, B G Utterback, J A Jakubowski and G F Smith
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 546-552;

  2. Jakubowski, J A

    1. Pharmacological assessment of the antithrombotic activity of the peptide thrombin inhibitor, D-methyl-phenylalanyl-prolyl-arginal (GYKI-14766), in a canine model of coronary artery thrombosis.
      C V Jackson, V G Crowe, J D Frank, H C Wilson, W J Coffman, B G Utterback, J A Jakubowski and G F Smith
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 546-552;

  3. Jang, J

    1. Use of 2-hydroxypropyl-beta-cyclodextrin as an intrathecal drug vehicle with opioids.
      J Jang, T L Yaksh and H F Hill
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 592-600;

  4. Janssen, P A

    1. Liarozole, an inhibitor of retinoic acid metabolism, exerts retinoid-mimetic effects in vivo.
      J Van Wauwe, G Van Nyen, M C Coene, P Stoppie, W Cools, J Goossens, P Borghgraef and P A Janssen
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 773-779;

  5. Jobe, P C

    1. Evidence that carbamazepine and antiepilepsirine may produce a component of their anticonvulsant effects by activating serotonergic neurons in genetically epilepsy-prone rats.
      Q S Yan, P K Mishra, R L Burger, A F Bettendorf, P C Jobe and J W Dailey
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 652-659;

  6. Johnson, M

    1. Effects of 3,4-dihydroxymethamphetamine and 2,4,5-trihydroxymethamphetamine, two metabolites of 3,4-methylenedioxymethamphetamine, on central serotonergic and dopaminergic systems.
      M Johnson, I Elayan, G R Hanson, R L Foltz, J W Gibb and H K Lim
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 447-453;
    2. Effect of flunarizine and nimodipine on the decrease in tryptophan hydroxylase activity induced by methamphetamine and 3,4-methylenedioxymethamphetamine.
      M Johnson, K Mitros, D M Stone, R Zobrist, G R Hanson and J W Gibb
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 586-591;

  7. Jutras, L

    1. Effect of inflammation on the rabbit hepatic cytochrome P-450 isoenzymes: alterations in the kinetics and dynamics of tolbutamide.
      C Parent, P M Bélanger, L Jutras and P du Souich
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 780-787;

K

  1. Kalivas, P W

    1. Microinjection of the D2 agonist quinpirole into the A10 dopamine region blocks amphetamine-, but not cocaine-stimulated motor activity.
      J D Steketee and P W Kalivas
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 811-818;

  2. Karaki, H

    1. Myosin phosphorylation-independent contraction induced by phorbol ester in vascular smooth muscle.
      K Sato, M Hori, H Ozaki, H Takano-Ohmuro, T Tsuchiya, H Sugi and H Karaki
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 497-505;
    2. Receptor agonists induce myosin phosphorylation-dependent and phosphorylation-independent contractions in vascular smooth muscle.
      M Hori, K Sato, K Sakata, H Ozaki, H Takano-Ohmuro, T Tsuchiya, H Sugi, I Kato and H Karaki
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 506-512;

  3. Kato, I

    1. Receptor agonists induce myosin phosphorylation-dependent and phosphorylation-independent contractions in vascular smooth muscle.
      M Hori, K Sato, K Sakata, H Ozaki, H Takano-Ohmuro, T Tsuchiya, H Sugi, I Kato and H Karaki
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 506-512;

  4. Katoh, A

    1. Y-27152, a long-acting K+ channel opener with less tachycardia: antihypertensive effects in hypertensive rats and dogs in conscious state.
      T Nakajima, T Shinohara, O Yaoka, A Fukunari, K Shinagawa, K Aoki, A Katoh, T Yamanaka, M Setoguchi and T Tahara
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 730-736;

  5. Katz, J L

    1. Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations.
      G A Ricaurte, A L Martello, J L Katz and M B Martello
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 616-622;

  6. Kinter, L B

    1. Vasopressin antagonist inhibition of clotting factor release in the rhesus monkey (Macaca mulatta).
      L B Kinter, I McConnell, B T Goodwin, S Campbell, W F Huffman, M F Arthus, M Lonergan and D G Bichet
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 462-469;

  7. Kirkeby, H J

    1. Functional effects, binding sites and immunolocalization of endothelin-1 in isolated penile tissues from man and rabbit.
      F Holmquist, H J Kirkeby, B Larsson, A Forman, P Alm and K E Andersson
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 795-802;

  8. Koob, G F

    1. Role of different brain structures in the expression of the physical morphine withdrawal syndrome.
      R Maldonado, L Stinus, L H Gold and G F Koob
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 669-677;

  9. Kura, H

    1. Blocking action of terodiline on calcium channels in single smooth muscle cells of the guinea pig urinary bladder.
      H Kura, M Yoshino and H Yabu
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 724-729;

  10. Kurtzman, N A

    1. Effect of lithium and amiloride on collecting tubule transport enzymes.
      E Dafnis, N A Kurtzman and S Sabatini
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 701-706;

L

  1. Lahners, K N

    1. Perinatal changes in the coupling of beta 1- and beta 3 adrenergic receptors to brown fat adenylyl cyclase.
      A Chaudhry, K N Lahners and J G Granneman
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 633-637;

  2. Larsson, B

    1. Functional effects, binding sites and immunolocalization of endothelin-1 in isolated penile tissues from man and rabbit.
      F Holmquist, H J Kirkeby, B Larsson, A Forman, P Alm and K E Andersson
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 795-802;

  3. Lash, L H

    1. Mercuric chloride-induced cytotoxicity and compensatory hypertrophy in rat kidney proximal tubular cells.
      L H Lash and R K Zalups
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 819-829;

  4. Lavigne, G J

    1. Cholecystokinin type A and type B receptor antagonists produce opposing effects on cholecystokinin-stimulated beta-endorphin secretion from the rat pituitary.
      W R Millington, G P Mueller and G J Lavigne
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 454-461;

  5. Lehmann, H

    1. (+-)-1-hydroxy-3-aminopyrrolidone-2 (HA-966) inhibits the activity of substantia nigra dopamine neurons through a non-N-methyl-D-aspartate receptor-mediated mechanism.
      P D Shepard and H Lehmann
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 387-394;

  6. Lim, H K

    1. Effects of 3,4-dihydroxymethamphetamine and 2,4,5-trihydroxymethamphetamine, two metabolites of 3,4-methylenedioxymethamphetamine, on central serotonergic and dopaminergic systems.
      M Johnson, I Elayan, G R Hanson, R L Foltz, J W Gibb and H K Lim
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 447-453;

  7. Liu, Y

    1. Prolactin regulates maternal bile secretory function post partum.
      Y Liu, J F Hyde and M Vore
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 560-566;

  8. Lonergan, M

    1. Vasopressin antagonist inhibition of clotting factor release in the rhesus monkey (Macaca mulatta).
      L B Kinter, I McConnell, B T Goodwin, S Campbell, W F Huffman, M F Arthus, M Lonergan and D G Bichet
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 462-469;

  9. Lorenzo, P S

    1. Relaxant effects of beta-carbolines on rat aortic rings.
      B Elgoyhen, P S Lorenzo, M T Tellez-Iñón and E Adler-Graschinsky
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 534-539;

M

  1. Maldonado, R

    1. Role of different brain structures in the expression of the physical morphine withdrawal syndrome.
      R Maldonado, L Stinus, L H Gold and G F Koob
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 669-677;

  2. Malik, K U

    1. Adenosine receptor-mediated alterations in prostacyclin production and cardiac function in the isolated rabbit heart.
      C Cano and K U Malik
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 660-668;

  3. Manzo, L

    1. Benzimidazolone derivatives: a new class of 5-hydroxytryptamine4 receptor agonists with prokinetic and acetylcholine releasing properties in the guinea pig ileum.
      C A Rizzi, T Coccini, L Onori, L Manzo and M Tonini
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 412-419;

  4. Martello, A L

    1. Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations.
      G A Ricaurte, A L Martello, J L Katz and M B Martello
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 616-622;

  5. Martello, M B

    1. Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations.
      G A Ricaurte, A L Martello, J L Katz and M B Martello
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 616-622;

  6. Martin, W R

    1. Opioid and nicotinic analgesic and hyperalgesic loci in the rat brain stem.
      S R Hamann and W R Martin
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 707-715;

  7. McConnell, I

    1. Vasopressin antagonist inhibition of clotting factor release in the rhesus monkey (Macaca mulatta).
      L B Kinter, I McConnell, B T Goodwin, S Campbell, W F Huffman, M F Arthus, M Lonergan and D G Bichet
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 462-469;

  8. McDonald, B J

    1. Hepatic cytochrome P-450-mediated activation of rat aortic guanylyl cyclase by glyceryl trinitrate.
      B M Bennett, B J McDonald and M J St James
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 716-723;

  9. Mecca, T E

    1. Effect of clentiazem on arterial pressure and renal function in normotensive and hypertensive rats.
      F J Fenoy, I Milicic, M Mistry, T E Mecca and R J Roman
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 470-475;

  10. Milicic, I

    1. Effect of clentiazem on arterial pressure and renal function in normotensive and hypertensive rats.
      F J Fenoy, I Milicic, M Mistry, T E Mecca and R J Roman
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 470-475;

  11. Millington, W R

    1. Cholecystokinin type A and type B receptor antagonists produce opposing effects on cholecystokinin-stimulated beta-endorphin secretion from the rat pituitary.
      W R Millington, G P Mueller and G J Lavigne
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 454-461;

  12. Mishra, P K

    1. Evidence that carbamazepine and antiepilepsirine may produce a component of their anticonvulsant effects by activating serotonergic neurons in genetically epilepsy-prone rats.
      Q S Yan, P K Mishra, R L Burger, A F Bettendorf, P C Jobe and J W Dailey
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 652-659;

  13. Mistry, M

    1. Effect of clentiazem on arterial pressure and renal function in normotensive and hypertensive rats.
      F J Fenoy, I Milicic, M Mistry, T E Mecca and R J Roman
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 470-475;

  14. Mitros, K

    1. Effect of flunarizine and nimodipine on the decrease in tryptophan hydroxylase activity induced by methamphetamine and 3,4-methylenedioxymethamphetamine.
      M Johnson, K Mitros, D M Stone, R Zobrist, G R Hanson and J W Gibb
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 586-591;

  15. Mueller, G P

    1. Cholecystokinin type A and type B receptor antagonists produce opposing effects on cholecystokinin-stimulated beta-endorphin secretion from the rat pituitary.
      W R Millington, G P Mueller and G J Lavigne
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 454-461;

  16. Murgo, A J

    1. K562 leukemia cells express P2T (adenosine diphosphate) purinergic receptors.
      A J Murgo and F D Sistare
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 580-585;

  17. Myles, J L

    1. Characterization of 5-hydroxytryptamine receptors in bovine coronary arteries.
      R A Foy, J L Myles and R D Wilkerson
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 601-606;

N

  1. Nakajima, T

    1. Y-27152, a long-acting K+ channel opener with less tachycardia: antihypertensive effects in hypertensive rats and dogs in conscious state.
      T Nakajima, T Shinohara, O Yaoka, A Fukunari, K Shinagawa, K Aoki, A Katoh, T Yamanaka, M Setoguchi and T Tahara
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 730-736;

  2. Near, J A

    1. Effect of chronic haloperidol treatment on stimulated synaptic overflow of dopamine in the rat striatum.
      D J Wiedemann, P A Garris, J A Near and R M Wightman
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 574-579;

  3. Nemec, J

    1. Human cytochrome P450 metabolism of teniposide and etoposide.
      M V Relling, R Evans, C Dass, D M Desiderio and J Nemec
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 491-496;

O

  1. Ogasawara, S

    1. Alpha adrenoceptor subtypes involved in the emetic action in dogs.
      Y Hikasa, S Ogasawara and K Takase
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 746-754;

  2. Olsen, G D

    1. In utero cocaine exposure: effect on neonatal breathing in guinea pigs.
      G D Olsen and J A Weil
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 420-428;

  3. Onori, L

    1. Benzimidazolone derivatives: a new class of 5-hydroxytryptamine4 receptor agonists with prokinetic and acetylcholine releasing properties in the guinea pig ileum.
      C A Rizzi, T Coccini, L Onori, L Manzo and M Tonini
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 412-419;

  4. Ozaki, H

    1. Myosin phosphorylation-independent contraction induced by phorbol ester in vascular smooth muscle.
      K Sato, M Hori, H Ozaki, H Takano-Ohmuro, T Tsuchiya, H Sugi and H Karaki
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 497-505;
    2. Receptor agonists induce myosin phosphorylation-dependent and phosphorylation-independent contractions in vascular smooth muscle.
      M Hori, K Sato, K Sakata, H Ozaki, H Takano-Ohmuro, T Tsuchiya, H Sugi, I Kato and H Karaki
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 506-512;

P

  1. Pahapill, P A

    1. Dual action of 2,3-butanedione monoxime (BDM) on K+ current in human T lymphocytes.
      L C Schlichter, P A Pahapill and I Chung
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 438-446;

  2. Papachristou, D N

    1. The alcohol-preferring C57BL/6 mice present an enhanced sensitivity of the hypothalamic beta-endorphin system to ethanol than the alcohol-avoiding DBA/2 mice.
      J P De Waele, D N Papachristou and C Gianoulakis
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 788-794;

  3. Parent, C

    1. Effect of inflammation on the rabbit hepatic cytochrome P-450 isoenzymes: alterations in the kinetics and dynamics of tolbutamide.
      C Parent, P M Bélanger, L Jutras and P du Souich
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 780-787;

  4. Phillips, T J

    1. Acute sensitivity of FAST and SLOW mice to the effects of abused drugs on locomotor activity.
      T J Phillips, S Burkhart-Kasch, C C Gwiazdon and J C Crabbe
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 525-533;

  5. Pinkus, L M

    1. AHR-9294: a novel inhibitor of H,K-ATPase antagonizes gastric HCl secretion in vivo.
      W W Reenstra, L M Pinkus, J Bailey, W L Smith, D Droppleman, L F Sancilio and J G Forte
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 737-745;

R

  1. Ramwell, P W

    1. Estradiol potentiates the vasopressor response of the isolated perfused rat lung to the thromboxane mimic U-46619.
      M Y Farhat and P W Ramwell
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 686-691;

  2. Reenstra, W W

    1. AHR-9294: a novel inhibitor of H,K-ATPase antagonizes gastric HCl secretion in vivo.
      W W Reenstra, L M Pinkus, J Bailey, W L Smith, D Droppleman, L F Sancilio and J G Forte
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 737-745;

  3. Relling, M V

    1. Human cytochrome P450 metabolism of teniposide and etoposide.
      M V Relling, R Evans, C Dass, D M Desiderio and J Nemec
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 491-496;

  4. Ricaurte, G A

    1. Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations.
      G A Ricaurte, A L Martello, J L Katz and M B Martello
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 616-622;

  5. Ricci, A

    1. Endothelial dopamine DA-1 receptor sites in the rabbit pulmonary artery: autoradiographic demonstration.
      A Ricci, W L Collier and F Amenta
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 830-834;

  6. Rizzi, C A

    1. Benzimidazolone derivatives: a new class of 5-hydroxytryptamine4 receptor agonists with prokinetic and acetylcholine releasing properties in the guinea pig ileum.
      C A Rizzi, T Coccini, L Onori, L Manzo and M Tonini
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 412-419;

  7. Roch-Ramel, F

    1. Transport of salicylic acid through monolayers of a kidney epithelial cell line (LLC-PK1).
      J Y Chatton and F Roch-Ramel
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 518-524;

  8. Roman, R J

    1. Effect of clentiazem on arterial pressure and renal function in normotensive and hypertensive rats.
      F J Fenoy, I Milicic, M Mistry, T E Mecca and R J Roman
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 470-475;

S

  1. Sabatini, S

    1. Effect of lithium and amiloride on collecting tubule transport enzymes.
      E Dafnis, N A Kurtzman and S Sabatini
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 701-706;

  2. Sakata, K

    1. Receptor agonists induce myosin phosphorylation-dependent and phosphorylation-independent contractions in vascular smooth muscle.
      M Hori, K Sato, K Sakata, H Ozaki, H Takano-Ohmuro, T Tsuchiya, H Sugi, I Kato and H Karaki
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 506-512;

  3. Sancilio, L F

    1. AHR-9294: a novel inhibitor of H,K-ATPase antagonizes gastric HCl secretion in vivo.
      W W Reenstra, L M Pinkus, J Bailey, W L Smith, D Droppleman, L F Sancilio and J G Forte
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 737-745;

  4. Sanger, D J

    1. Increased rates of punished responding produced by buspirone-like compounds in rats.
      D J Sanger
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 513-517;

  5. Sato, K

    1. Myosin phosphorylation-independent contraction induced by phorbol ester in vascular smooth muscle.
      K Sato, M Hori, H Ozaki, H Takano-Ohmuro, T Tsuchiya, H Sugi and H Karaki
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 497-505;
    2. Receptor agonists induce myosin phosphorylation-dependent and phosphorylation-independent contractions in vascular smooth muscle.
      M Hori, K Sato, K Sakata, H Ozaki, H Takano-Ohmuro, T Tsuchiya, H Sugi, I Kato and H Karaki
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 506-512;

  6. Schini, V B

    1. Inhibitors of calmodulin impair the constitutive but not the inducible nitric oxide synthase activity in the rat aorta.
      V B Schini and P M Vanhoutte
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 553-559;

  7. Schlichter, L C

    1. Dual action of 2,3-butanedione monoxime (BDM) on K+ current in human T lymphocytes.
      L C Schlichter, P A Pahapill and I Chung
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 438-446;

  8. Setoguchi, M

    1. Y-27152, a long-acting K+ channel opener with less tachycardia: antihypertensive effects in hypertensive rats and dogs in conscious state.
      T Nakajima, T Shinohara, O Yaoka, A Fukunari, K Shinagawa, K Aoki, A Katoh, T Yamanaka, M Setoguchi and T Tahara
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 730-736;

  9. Shaw, D J

    1. The inhibitory effects of cromakalim and its active enantiomer BRL 38227 against various agonists in guinea pig and human airways: comparison with pinacidil and verapamil.
      S G Taylor, J R Arch, J Bond, D R Buckle, D J Shaw, J F Taylor and J S Ward
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 429-437;

  10. Shepard, P D

    1. (+-)-1-hydroxy-3-aminopyrrolidone-2 (HA-966) inhibits the activity of substantia nigra dopamine neurons through a non-N-methyl-D-aspartate receptor-mediated mechanism.
      P D Shepard and H Lehmann
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 387-394;

  11. Shinagawa, K

    1. Y-27152, a long-acting K+ channel opener with less tachycardia: antihypertensive effects in hypertensive rats and dogs in conscious state.
      T Nakajima, T Shinohara, O Yaoka, A Fukunari, K Shinagawa, K Aoki, A Katoh, T Yamanaka, M Setoguchi and T Tahara
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 730-736;

  12. Shinohara, T

    1. Y-27152, a long-acting K+ channel opener with less tachycardia: antihypertensive effects in hypertensive rats and dogs in conscious state.
      T Nakajima, T Shinohara, O Yaoka, A Fukunari, K Shinagawa, K Aoki, A Katoh, T Yamanaka, M Setoguchi and T Tahara
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 730-736;

  13. Sistare, F D

    1. K562 leukemia cells express P2T (adenosine diphosphate) purinergic receptors.
      A J Murgo and F D Sistare
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 580-585;

  14. Smith, G F

    1. Pharmacological assessment of the antithrombotic activity of the peptide thrombin inhibitor, D-methyl-phenylalanyl-prolyl-arginal (GYKI-14766), in a canine model of coronary artery thrombosis.
      C V Jackson, V G Crowe, J D Frank, H C Wilson, W J Coffman, B G Utterback, J A Jakubowski and G F Smith
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 546-552;

  15. Smith, W L

    1. AHR-9294: a novel inhibitor of H,K-ATPase antagonizes gastric HCl secretion in vivo.
      W W Reenstra, L M Pinkus, J Bailey, W L Smith, D Droppleman, L F Sancilio and J G Forte
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 737-745;

  16. Spealman, R D

    1. Modulation of the discriminative stimulus effects of cocaine by mu and kappa opioids.
      R D Spealman and J Bergman
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 607-615;

  17. Steketee, J D

    1. Microinjection of the D2 agonist quinpirole into the A10 dopamine region blocks amphetamine-, but not cocaine-stimulated motor activity.
      J D Steketee and P W Kalivas
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 811-818;

  18. Stinus, L

    1. Role of different brain structures in the expression of the physical morphine withdrawal syndrome.
      R Maldonado, L Stinus, L H Gold and G F Koob
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 669-677;

  19. St James, M J

    1. Hepatic cytochrome P-450-mediated activation of rat aortic guanylyl cyclase by glyceryl trinitrate.
      B M Bennett, B J McDonald and M J St James
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 716-723;

  20. Stone, D M

    1. Effect of flunarizine and nimodipine on the decrease in tryptophan hydroxylase activity induced by methamphetamine and 3,4-methylenedioxymethamphetamine.
      M Johnson, K Mitros, D M Stone, R Zobrist, G R Hanson and J W Gibb
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 586-591;

  21. Stoppie, P

    1. Liarozole, an inhibitor of retinoic acid metabolism, exerts retinoid-mimetic effects in vivo.
      J Van Wauwe, G Van Nyen, M C Coene, P Stoppie, W Cools, J Goossens, P Borghgraef and P A Janssen
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 773-779;

  22. Sugi, H

    1. Myosin phosphorylation-independent contraction induced by phorbol ester in vascular smooth muscle.
      K Sato, M Hori, H Ozaki, H Takano-Ohmuro, T Tsuchiya, H Sugi and H Karaki
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 497-505;
    2. Receptor agonists induce myosin phosphorylation-dependent and phosphorylation-independent contractions in vascular smooth muscle.
      M Hori, K Sato, K Sakata, H Ozaki, H Takano-Ohmuro, T Tsuchiya, H Sugi, I Kato and H Karaki
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 506-512;

T

  1. Tagliente, T M

    1. Phasic responses to carbachol in isolated guinea pig trachea are augmented by cooling and inhibited by nifedipine.
      T M Tagliente, B A Dalton and R R Ben-Harari
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 755-763;

  2. Tahara, T

    1. Y-27152, a long-acting K+ channel opener with less tachycardia: antihypertensive effects in hypertensive rats and dogs in conscious state.
      T Nakajima, T Shinohara, O Yaoka, A Fukunari, K Shinagawa, K Aoki, A Katoh, T Yamanaka, M Setoguchi and T Tahara
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 730-736;

  3. Takano, Y

    1. Characterization of the pharmacology of intrathecally administered alpha-2 agonists and antagonists in rats.
      Y Takano and T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 764-772;

  4. Takano-Ohmuro, H

    1. Myosin phosphorylation-independent contraction induced by phorbol ester in vascular smooth muscle.
      K Sato, M Hori, H Ozaki, H Takano-Ohmuro, T Tsuchiya, H Sugi and H Karaki
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 497-505;
    2. Receptor agonists induce myosin phosphorylation-dependent and phosphorylation-independent contractions in vascular smooth muscle.
      M Hori, K Sato, K Sakata, H Ozaki, H Takano-Ohmuro, T Tsuchiya, H Sugi, I Kato and H Karaki
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 506-512;

  5. Takase, K

    1. Alpha adrenoceptor subtypes involved in the emetic action in dogs.
      Y Hikasa, S Ogasawara and K Takase
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 746-754;

  6. Tassin, J P

    1. Nicotine and morphine differentially activate brain dopamine in prefrontocortical and subcortical terminal fields: effects of acute and repeated injections.
      P Vezina, G Blanc, J Glowinski and J P Tassin
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 484-490;

  7. Taylor, J F

    1. The inhibitory effects of cromakalim and its active enantiomer BRL 38227 against various agonists in guinea pig and human airways: comparison with pinacidil and verapamil.
      S G Taylor, J R Arch, J Bond, D R Buckle, D J Shaw, J F Taylor and J S Ward
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 429-437;

  8. Taylor, S G

    1. The inhibitory effects of cromakalim and its active enantiomer BRL 38227 against various agonists in guinea pig and human airways: comparison with pinacidil and verapamil.
      S G Taylor, J R Arch, J Bond, D R Buckle, D J Shaw, J F Taylor and J S Ward
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 429-437;

  9. Tellez-Iñón, M T

    1. Relaxant effects of beta-carbolines on rat aortic rings.
      B Elgoyhen, P S Lorenzo, M T Tellez-Iñón and E Adler-Graschinsky
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 534-539;

  10. Tonini, M

    1. Benzimidazolone derivatives: a new class of 5-hydroxytryptamine4 receptor agonists with prokinetic and acetylcholine releasing properties in the guinea pig ileum.
      C A Rizzi, T Coccini, L Onori, L Manzo and M Tonini
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 412-419;

  11. Tseng, L F

    1. Involvement of dynorphin A and not substance P in the spinal antianalgesic action of capsaicin against morphine-induced antinociception in mice.
      K S Arts, J M Fujimoto and L F Tseng
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 643-651;

  12. Tsuchiya, T

    1. Myosin phosphorylation-independent contraction induced by phorbol ester in vascular smooth muscle.
      K Sato, M Hori, H Ozaki, H Takano-Ohmuro, T Tsuchiya, H Sugi and H Karaki
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 497-505;
    2. Receptor agonists induce myosin phosphorylation-dependent and phosphorylation-independent contractions in vascular smooth muscle.
      M Hori, K Sato, K Sakata, H Ozaki, H Takano-Ohmuro, T Tsuchiya, H Sugi, I Kato and H Karaki
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 506-512;

  13. Tyler, C B

    1. Acute administration of amphetamine: differential regulation of dopamine synthesis in dopamine projection fields.
      C B Tyler and M P Galloway
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 567-573;

  14. Tzeng, T B

    1. Pharmacokinetic/pharmacodynamic relationship of the duration of vasodilating action of organic mononitrates in rats.
      T B Tzeng and H L Fung
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 692-700;

U

  1. Utterback, B G

    1. Pharmacological assessment of the antithrombotic activity of the peptide thrombin inhibitor, D-methyl-phenylalanyl-prolyl-arginal (GYKI-14766), in a canine model of coronary artery thrombosis.
      C V Jackson, V G Crowe, J D Frank, H C Wilson, W J Coffman, B G Utterback, J A Jakubowski and G F Smith
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 546-552;

V

  1. Vanhoutte, P M

    1. Inhibitors of calmodulin impair the constitutive but not the inducible nitric oxide synthase activity in the rat aorta.
      V B Schini and P M Vanhoutte
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 553-559;

  2. Van Nyen, G

    1. Liarozole, an inhibitor of retinoic acid metabolism, exerts retinoid-mimetic effects in vivo.
      J Van Wauwe, G Van Nyen, M C Coene, P Stoppie, W Cools, J Goossens, P Borghgraef and P A Janssen
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 773-779;

  3. Van Wauwe, J

    1. Liarozole, an inhibitor of retinoic acid metabolism, exerts retinoid-mimetic effects in vivo.
      J Van Wauwe, G Van Nyen, M C Coene, P Stoppie, W Cools, J Goossens, P Borghgraef and P A Janssen
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 773-779;

  4. Vezina, P

    1. Nicotine and morphine differentially activate brain dopamine in prefrontocortical and subcortical terminal fields: effects of acute and repeated injections.
      P Vezina, G Blanc, J Glowinski and J P Tassin
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 484-490;

  5. Vore, M

    1. Prolactin regulates maternal bile secretory function post partum.
      Y Liu, J F Hyde and M Vore
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 560-566;

W

  1. Wang, J Q

    1. Centrally mediated cardiovascular actions of dynorphin A(1-8) on rat hippocampal formation.
      J Q Wang and A J Ingenito
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 678-685;

  2. Ward, J S

    1. The inhibitory effects of cromakalim and its active enantiomer BRL 38227 against various agonists in guinea pig and human airways: comparison with pinacidil and verapamil.
      S G Taylor, J R Arch, J Bond, D R Buckle, D J Shaw, J F Taylor and J S Ward
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 429-437;

  3. Weil, J A

    1. In utero cocaine exposure: effect on neonatal breathing in guinea pigs.
      G D Olsen and J A Weil
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 420-428;

  4. Wiedemann, D J

    1. Effect of chronic haloperidol treatment on stimulated synaptic overflow of dopamine in the rat striatum.
      D J Wiedemann, P A Garris, J A Near and R M Wightman
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 574-579;

  5. Wightman, R M

    1. Effect of chronic haloperidol treatment on stimulated synaptic overflow of dopamine in the rat striatum.
      D J Wiedemann, P A Garris, J A Near and R M Wightman
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 574-579;

  6. Wilkerson, R D

    1. Characterization of 5-hydroxytryptamine receptors in bovine coronary arteries.
      R A Foy, J L Myles and R D Wilkerson
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 601-606;

  7. Williams, J T

    1. Sensitization of locus ceruleus neurons during withdrawal from chronic stimulants and antidepressants.
      G C Harris and J T Williams
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 476-483;

  8. Williams, P J

    1. Direct in vitro electrochemical measurement of dopamine overflow in intermediate pituitary: characterization and pharmacology.
      P J Williams, T V Dunwiddie and G A Gerhardt
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 403-411;

  9. Wilson, H C

    1. Pharmacological assessment of the antithrombotic activity of the peptide thrombin inhibitor, D-methyl-phenylalanyl-prolyl-arginal (GYKI-14766), in a canine model of coronary artery thrombosis.
      C V Jackson, V G Crowe, J D Frank, H C Wilson, W J Coffman, B G Utterback, J A Jakubowski and G F Smith
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 546-552;

  10. Windebank, A J

    1. Emulsifier for intravenous cyclosporin inhibits neurite outgrowth, causes deficits in rapid axonal transport and leads to structural abnormalities in differentiating N1E.115 neuroblastoma.
      D J Brat, A J Windebank and S Brimijoin
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 803-810;

Y

  1. Yabu, H

    1. Blocking action of terodiline on calcium channels in single smooth muscle cells of the guinea pig urinary bladder.
      H Kura, M Yoshino and H Yabu
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 724-729;

  2. Yaksh, T L

    1. Use of 2-hydroxypropyl-beta-cyclodextrin as an intrathecal drug vehicle with opioids.
      J Jang, T L Yaksh and H F Hill
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 592-600;
    2. Characterization of the pharmacology of intrathecally administered alpha-2 agonists and antagonists in rats.
      Y Takano and T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 764-772;

  3. Yamanaka, T

    1. Y-27152, a long-acting K+ channel opener with less tachycardia: antihypertensive effects in hypertensive rats and dogs in conscious state.
      T Nakajima, T Shinohara, O Yaoka, A Fukunari, K Shinagawa, K Aoki, A Katoh, T Yamanaka, M Setoguchi and T Tahara
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 730-736;

  4. Yan, Q S

    1. Evidence that carbamazepine and antiepilepsirine may produce a component of their anticonvulsant effects by activating serotonergic neurons in genetically epilepsy-prone rats.
      Q S Yan, P K Mishra, R L Burger, A F Bettendorf, P C Jobe and J W Dailey
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 652-659;

  5. Yaoka, O

    1. Y-27152, a long-acting K+ channel opener with less tachycardia: antihypertensive effects in hypertensive rats and dogs in conscious state.
      T Nakajima, T Shinohara, O Yaoka, A Fukunari, K Shinagawa, K Aoki, A Katoh, T Yamanaka, M Setoguchi and T Tahara
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 730-736;

  6. Yoshino, M

    1. Blocking action of terodiline on calcium channels in single smooth muscle cells of the guinea pig urinary bladder.
      H Kura, M Yoshino and H Yabu
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 724-729;

Z

  1. Zalups, R K

    1. Mercuric chloride-induced cytotoxicity and compensatory hypertrophy in rat kidney proximal tubular cells.
      L H Lash and R K Zalups
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 819-829;

  2. Zhang, X

    1. Effects of lorazepam tolerance and withdrawal on GABAA receptor-operated chloride channels.
      A M Allan, L D Baier and X Zhang
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 395-402;

  3. Zobrist, R

    1. Effect of flunarizine and nimodipine on the decrease in tryptophan hydroxylase activity induced by methamphetamine and 3,4-methylenedioxymethamphetamine.
      M Johnson, K Mitros, D M Stone, R Zobrist, G R Hanson and J W Gibb
      Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 586-591;
Back to top

In this issue